100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human anti-GBM (Anti glomerular basement membrane antibody) ELISA Kit (AEFI00267)

SKU AEFI00267
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antigen
Sensitivity 0.938 ng/mL
Range 1.563-100 ng/mL
€649 - €5,841

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human anti-GBM (Anti glomerular basement membrane antibody) ELISA Kit

The Human Anti-GBM (Anti-Glomerular Basement Membrane) Antibody ELISA Kit is a specialized diagnostic tool for detecting antibodies specific to the glomerular basement membrane in human serum samples. This kit offers high sensitivity and accuracy, allowing for precise measurement of anti-GBM antibody levels in a variety of clinical and research settings. Anti-GBM antibodies are an important marker for autoimmune diseases such as Goodpasture syndrome and in the diagnosis and monitoring of renal disorders. The detection of these antibodies can aid in early diagnosis, prognosis, and treatment planning for patients with these conditions.

With its reliable performance and ease of use, the Human Anti-GBM Antibody ELISA Kit is a valuable tool for researchers and healthcare professionals working in nephrology, immunology, and autoimmune disease research. Additionally, it provides a means for monitoring disease progression and evaluating treatment efficacy in patients with anti-GBM antibody-associated disorders.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose